Clinical Trials on Anti-SARS-CoV-2 Antibody Response in Colombia
Total 47 results
-
Ridgeback Biotherapeutics, LPMerck Sharp & Dohme LLCCompletedSARS-CoV 2United States
-
Hospital San Vicente FundaciónHospital Pablo Tobón Uribe; Clínica León XIII; Grupo de Inmunodeficiencias primarias... and other collaboratorsUnknown
-
University of Missouri-ColumbiaCompletedSARS-CoV 2 | SARS PneumoniaUnited States
-
ModernaTX, Inc.RecruitingSARS-CoV-2United States, Puerto Rico
-
University of Missouri-ColumbiaCompletedSARS-CoV 2 | ARDSUnited States
-
AstraZenecaCompletedSARS-CoV-2United States, Belgium, United Kingdom, Brazil, Germany
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.Recruiting
-
ModernaTX, Inc.National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...Completed
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR)Enrolling by invitationSARS-CoV-2 Infection | Post-acute Sequelae of SARS-CoV-2Canada
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
University of Los Andes, ColumbiaUnited NationsCompletedSARS-CoV-2 InfectionColombia
-
Hospital Universitario San IgnacioPontificia Universidad JaverianaRecruitingCoronavirus Infection | SARS-CoV 2 | COVID | COVID19Colombia
-
NovafemCompletedSARS-CoV-2 Infection | Ovarian Reserve | BlastocystColombia
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
University of Missouri-ColumbiaCompleted
-
United Medical SpecialtiesRecruiting
-
AstraZenecaCompletedCOVID-19, SARS-CoV-2Mexico, Brazil, Colombia, Costa Rica, Panama
-
Javier EslavaCompletedCOVID-19 | Long COVID | Post-acute COVID-19 Syndrome | Long-COVID | Post-acute Sequelae of SARS-CoV-2 InfectionColombia
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompletedCOVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
-
National Institute of Allergy and Infectious Diseases...Teva Pharmaceutical Industries, Ltd.TerminatedCOVID-19 | SARS-CoV 2United States
-
University of CalgaryHealth CanadaCompleted
-
Valentin FusterCompletedCOVID-19 | SARS-CoV-2United States, Colombia, India, Mexico, Brazil
-
Children's National Research InstituteRecruitingSARS-CoV-2 InfectionUnited States
-
Partner Therapeutics, Inc.United States Department of DefenseCompleted
-
CureVacCompletedCovid19 | SARS-CoV-2Belgium, Spain, Germany, Argentina, Colombia, Dominican Republic, Mexico, Netherlands, Panama, Peru
-
Vanderbilt University Medical CenterNational Center for Advancing Translational Sciences (NCATS); Dolly PartonCompletedCOVID-19 | SARS-CoV-2 | CoronavirusUnited States
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.CompletedSARS-CoV-2 | Coronavirus Disease 2019 (COVID-19)United States
-
Dentaid SLFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaboratorsCompleted
-
HIV Vaccine Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); HIV Prevention...CompletedCOVID-19 | SARS-CoV-2United States, Zimbabwe, Malawi, Peru, South Africa, Zambia
-
Blade TherapeuticsClinipace WorldwideCompletedCovid19 | Sars-CoV-2United States, Brazil
-
Hospices Civils de LyonCompletedSevere Acute Respiratory Syndrome Coronavirus 2 | Infection, CoronavirusFrance
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Inovio PharmaceuticalsAdvaccine (Suzhou) Biopharmaceuticals Co., Ltd.TerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Infection | COVID-19 DiseaseUnited States, Mexico, Colombia
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
aTyr Pharma, Inc.CompletedSARS-CoV-2 (COVID-19) Severe PneumoniaUnited States, Puerto Rico
-
PfizerActive, not recruitingCOVID-19 | Influenza, Human | SARS-CoV-2 InfectionUnited States
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
MediMergent, LLCTerminatedSARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID-19United States, Spain, Finland, Poland, Mexico, Brazil
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...CompletedSARS-CoV-2 InfectionUnited States
-
University of South CarolinaNational Institute of Nursing Research (NINR)RecruitingCardiovascular Diseases | Stroke | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Disease | SARS- CoV-2United States
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...RecruitingInfluenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
-
Thermo Fisher Scientific, IncNAMSACompletedSARS-CoV-2 Infection | Influenza A | RSV Infection | Influenza Type BUnited States